COMMUNIQUÉS West-GlobeNewswire

Natural Brain Support Without the Crash: Lives Potions Introduces Plant-Based Cognitive Enhancement
24/07/2025
This Herbal Brain Booster supports short-term focus and long-term brain health, offering calm, clean mental energy without jitters or burnout Brooklyn, NY, July 24, 2025 (GLOBE NEWSWIRE) -- Lives Potions is making waves [...]
Guerbet : Chiffre d’affaires du 1er semestre 2025
24/07/2025
Chiffre d’affaires du 1 er semestre 2025 Activité semestrielle Un chiffre d’affaires à mi-exercice de 387,8 M€, marquant un repli de 5,4% à TCC 1 et périmètre comparable 2 très largement dû à la baisse d’activité en [...]
Guerbet : H1 2025 revenue
24/07/2025
H1 2025 revenue First-half activity H1 revenue of €387.8 million, down 5.4% at CER 1 and like-for-like 2 largely due to the fall in activity in France Sales at CER and on a like-for-like basis increased in EMEA [...]
Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics
24/07/2025
BUFFALO, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Omniscient (o8t®), the global leader in connectomics, is proud to announce a groundbreaking partnership with The Jacobs Institute, Inc. (JI), a one-of-a-kind non-profit [...]
Fairhaven Health Strengthens Women’s Health Commitment Beyond Fertility
24/07/2025
MIDDLETOWN, Conn., July 24, 2025 (GLOBE NEWSWIRE) -- As the world honors World IVF Day, Fairhaven Health — a company long recognized by reproductive health professionals for its fertility-focused supplements — is [...]
Approbation de Cabometyx® dans l’UE pour les tumeurs neuroendocrines avancées précédemment traitées
24/07/2025
Cabometyx ® est le premier et unique traitement systémique autorisé dans l’Union européenne pour les tumeurs neuroendocrines non résécables ou métastatiques précédemment traitées, indépendamment de la localisation de la [...]
Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors
24/07/2025
Cabometyx ® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or previous non- [...]
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
24/07/2025
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs) RESEARCH TRIANGLE PARK, N.C., July 24, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics announces it [...]
Solésence To Report Second Quarter 2025 Financial Results and Host a Conference Call
24/07/2025
ROMEOVILLE, Ill., July 24, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company [...]
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025
24/07/2025
SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) immunotherapies, today [...]
Pacira to Report Second Quarter 2025 Financial Results on Tuesday August 5, 2025
24/07/2025
BRISBANE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, [...]
Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer
24/07/2025
NEEDHAM, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]
Natural Appetite Suppressant: Why PhenQ Is the Safer Choice Over Weight Loss Injections in 2025
24/07/2025
Newark, NJ, July 24, 2025 (GLOBE NEWSWIRE) -- PhenQ Leads the 2025 Weight Loss Revolution with a Science-Backed Natural Appetite Suppressant – No Injections, No Harsh Side Effects, Just Sustainable Weight Control [...]
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market
24/07/2025
WILSONVILLE, Ore. and DUBLIN, July 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including [...]
iSpecimen Inc. Announces Pricing of $4 Million Underwritten Offering
24/07/2025
WOBURN, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- iSpecimen Inc . (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a [...]
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025
24/07/2025
SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call
24/07/2025
SAN CLEMENTE, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter [...]
Liminatus Pharma Inc. Takes Next Step in Evaluating Digital Asset-Linked Capital Strategy
24/07/2025
Agreement with Digital Offering Advances Company's plan to assess innovative treasury-backed financing paths LA PALMA, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage [...]
Mersana Therapeutics Announces 1-for-25 Reverse Stock Split
24/07/2025
CAMBRIDGE, Mass., July 24, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers [...]

Pages